Xylem (NYSE:XYL) Price Target Raised to $135.00

Xylem (NYSE:XYL) had its price objective hoisted by TD Cowen from $130.00 to $135.00 in a research report report published on Friday,Benzinga reports. They currently have a hold rating on the industrial products company’s stock.

Several other analysts have also recently weighed in on XYL. Argus set a $170.00 price target on Xylem in a report on Wednesday, October 29th. Cowen reaffirmed a “hold” rating on shares of Xylem in a research report on Friday. Stifel Nicolaus boosted their price objective on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Royal Bank Of Canada increased their target price on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Finally, Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $167.40.

Xylem Trading Down 1.3%

XYL stock opened at $139.01 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50. The company has a fifty day moving average price of $145.86 and a two-hundred day moving average price of $138.68. Xylem has a one year low of $100.47 and a one year high of $154.27. The stock has a market cap of $33.85 billion, a price-to-earnings ratio of 35.74, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same period in the prior year, the firm earned $1.11 earnings per share. The company’s revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Equities analysts anticipate that Xylem will post 4.65 EPS for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th will be issued a $0.40 dividend. The ex-dividend date is Tuesday, November 25th. This represents a $1.60 annualized dividend and a yield of 1.2%. Xylem’s dividend payout ratio is presently 41.13%.

Insiders Place Their Bets

In related news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the transaction, the director owned 16,875 shares in the company, valued at $2,499,862.50. The trade was a 9.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of the stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Xylem

A number of hedge funds have recently added to or reduced their stakes in XYL. Vanguard Group Inc. grew its stake in shares of Xylem by 0.7% in the 3rd quarter. Vanguard Group Inc. now owns 29,902,236 shares of the industrial products company’s stock worth $4,410,580,000 after acquiring an additional 204,407 shares in the last quarter. State Street Corp grew its position in Xylem by 1.2% in the 3rd quarter. State Street Corp now owns 10,953,206 shares of the industrial products company’s stock worth $1,615,598,000 after purchasing an additional 133,173 shares in the last quarter. Geode Capital Management LLC increased its stake in Xylem by 2.3% in the 2nd quarter. Geode Capital Management LLC now owns 6,141,231 shares of the industrial products company’s stock valued at $791,029,000 after buying an additional 136,605 shares during the last quarter. Amundi lifted its position in shares of Xylem by 17.0% during the 2nd quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock worth $730,717,000 after buying an additional 830,337 shares in the last quarter. Finally, Impax Asset Management Group plc boosted its stake in shares of Xylem by 13.7% in the 2nd quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock worth $709,183,000 after buying an additional 663,191 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.